does medicare cover tirzepatide for weight loss President Trump announced that will semaglutide (Wegovy) and (Zepbound) management indications for people with obesity. Our senior staff writer Kristen Monaco What to know about Medicare

Oral bioavailability for systemic effects remains unproven in humans

Our mass torts attorneys are investigating claims that the manufacturers of these widely prescribed diabetes and weight-loss medications failed to warn patients about the risk of NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy), a serious and often permanent eye condition

Journal of Gastrointestinal Cancer 54(4):1308-1315, 2023

Having a quick reference eliminates the need to recalculate before each injection and reduces the chance of memory-based errors

A 2025 meta-analysis of randomized controlled trials found significant blood pressure effects (PMID: 41000008), and a separate meta-analysis focused on individuals with insulin resistance and chronic diseases found similar patterns (PMID: 28724644)

As such, other mechanisms might exist